Interpreting Economic Evaluations of Medicines A. T. DenbyN. E. J. Wells Guest Editorial 06 December 2012 Pages: 95 - 98
Erratum to The MOS 36-item short form health survey (SF-36): I. Conceptual framework J. E. WareC. D. Sherbourne Erratum 06 December 2012 Pages: 98 - 98
Erratum to Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF) Diana FauldsNancy J. W. LewisRichard J. Milne Erratum 06 December 2012 Pages: 98 - 98
The Influence of Pharmacoeconomic Factors on Prescribing Patterns in Ireland John Feely Leading Article 06 December 2012 Pages: 99 - 106
Interpreting Pharmacoeconomic and Quality-of-Life Clinical Trial Data for Use in Therapeutics Marcia A. TestaWilliam R. Lenderking Leading Article 06 December 2012 Pages: 107 - 117
Selegiline Harriet M. BrysonRichard J. MilnePaul Chrisp Pharmacoeconomic Drug Evaluation 06 December 2012 Pages: 118 - 136
The UK Indicative Prescribing Scheme John BlighTom Walley Review Article 06 December 2012 Pages: 137 - 152
Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug Therapies Douglas CoyleKeith Tolley Review Article 06 December 2012 Pages: 153 - 162
Costing Wound Infection in a Scottish Hospital W. LynchM. MalekA. Napier Original Research Article 06 December 2012 Pages: 163 - 170
Economic Evaluation of Oral Ofloxacin Versus Standard Parenteral Therapy in the Treatment of Pneumonia Joseph MenzinDaniel M. HuseGerry Oster Original Research Article 06 December 2012 Pages: 171 - 177
Glossary of Terms Used in Pharmacoeconomic and Quality of Life Analyses OriginalPaper 06 December 2012 Pages: 178 - 179